IMAX (NYSE:IMAX – Free Report) had its price objective raised by Barrington Research from $46.00 to $50.00 in a research note published on Friday, Marketbeat reports. Barrington Research currently has an outperform rating on the stock.
Several other brokerages have also issued reports on IMAX. JPMorgan Chase & Co. dropped their price target on IMAX from $48.00 to $47.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Roth Capital raised their target price on IMAX to $48.00 and gave the company a “buy” rating in a research note on Thursday. Rosenblatt Securities reaffirmed a “buy” rating and issued a $47.00 target price on shares of IMAX in a research report on Monday, July 20th. Keefe, Bruyette & Woods reiterated a “market perform” rating and issued a $60.00 price target on shares of IMAX in a report on Friday, May 22nd. Finally, B. Riley Financial boosted their price objective on IMAX from $48.00 to $52.00 and gave the company a “buy” rating in a report on Monday. Ten equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $50.36.
Check Out Our Latest Research Report on IMAX
IMAX Stock Down 1.7%
IMAX (NYSE:IMAX – Get Free Report) last issued its quarterly earnings results on Thursday, July 23rd. The company reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.30 by $0.13. IMAX had a net margin of 9.84% and a return on equity of 15.65%. The business had revenue of $102.84 million for the quarter, compared to analysts’ expectations of $96.09 million. During the same quarter in the prior year, the firm posted $0.26 earnings per share. The business’s quarterly revenue was up 12.2% compared to the same quarter last year. As a group, equities analysts expect that IMAX will post 1.3 earnings per share for the current fiscal year.
Insider Buying and Selling at IMAX
In other news, CEO Richard L. Gelfond sold 8,943 shares of IMAX stock in a transaction on Monday, April 27th. The shares were sold at an average price of $37.33, for a total transaction of $333,842.19. Following the completion of the sale, the chief executive officer directly owned 765,002 shares of the company’s stock, valued at approximately $28,557,524.66. The trade was a 1.16% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 20.55% of the company’s stock.
Institutional Trading of IMAX
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Orbis Allan Gray Ltd grew its holdings in shares of IMAX by 31.7% during the 2nd quarter. Orbis Allan Gray Ltd now owns 5,113,033 shares of the company’s stock valued at $142,960,000 after purchasing an additional 1,230,267 shares during the last quarter. Westfield Capital Management Co. LP grew its position in IMAX by 44.6% during the 4th quarter. Westfield Capital Management Co. LP now owns 2,346,486 shares of the company’s stock worth $86,726,000 after acquiring an additional 723,861 shares during the last quarter. Marsico Capital Management LLC bought a new position in IMAX during the 4th quarter worth approximately $18,149,000. Balyasny Asset Management L.P. purchased a new position in IMAX in the 2nd quarter worth approximately $12,568,000. Finally, Nuveen LLC increased its stake in IMAX by 253.0% in the 4th quarter. Nuveen LLC now owns 507,377 shares of the company’s stock worth $18,753,000 after purchasing an additional 363,658 shares during the period. Hedge funds and other institutional investors own 93.51% of the company’s stock.
More IMAX News
Here are the key news stories impacting IMAX this week:
- Positive Sentiment: IMAX reported better-than-expected second-quarter results, with EPS and revenue both topping Wall Street estimates, while management reaffirmed full-year guidance and highlighted margin expansion and network growth. IMAX Corporation Reports Second Quarter 2026 Results
- Positive Sentiment: Strong box-office traction for The Odyssey is boosting confidence that IMAX can sustain higher ticket sales and premium-screen utilization, with reports suggesting the film could be a transformational release for the company. The Odyssey is cleaning up for IMAX. Expect the momentum to continue
- Positive Sentiment: Analysts turned more bullish after earnings, with JPMorgan, Wells Fargo, Barrington, and Wedbush all raising price targets, and Wedbush reiterating Outperform on expectations for a stronger film pipeline, market-share gains, and international expansion. IMAX price target boosted by Wedbush on growth outlook
- Positive Sentiment: Investor attention is also being reinforced by unusual call-option activity and multiple stories about sold-out IMAX 70mm showings, signaling strong near-term demand sentiment around the stock. Imax’s CEO says it’s time to hike prices as tickets to ‘The Odyssey’ resell for $1,000
- Neutral Sentiment: IMAX disclosed a new regulatory risk tied to geopolitical, trade, and other global expansion challenges, which could matter over time but does not appear to be driving near-term trading. IMAX Confronts Rising Geopolitical, Regulatory and Trade Risks Threatening Global Expansion
About IMAX
IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.
Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.
Read More
- Five stocks we like better than IMAX
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.
